Grant: Travel Awards - Institute Community Support
Research Institute of the McGill University Health Centre
$1,500.00
The Spectrum of Nephrotic Syndrome from Minimal Change Disease to FSGS Correlates with Rac1 Activation
FY 2015-16
Summary
The main function of the kidneys is to filter the blood of waste products and produce urine. Within the kidneys are millions of glomeruli (singular:glomerulus) which are the sites where urine formation begins. The glomerulus functions as a filtration barrier that prevents the loss of important blood proteins into the urine. Nephrotic Syndrome (NS) is a disorder of the kidney
in which this filtration barrier is damaged and blood proteins are lost into the urine. It is common among children. The
consequences of heavy protein loss can include edema (swelling), infections, blood clots and in severe cases, the need for dialysis or
kidney transplantation to halt the protein loss. The severity and responsiveness to steroids is variable in NS.
The kidney's filtration barrier contains a population of cells known as podocytes
that are necessary for filtration function. Podocytes have a unique three-dimensional architecture with numerous small projections called foot processes that physically wrap around blood vessels, thereby blocking protein spillage into the urine. A family of proteins called Rho-GTPases regulate the three dimensional architecture of podocytes. The protein known as Rac1, is a key member
of the Rho-GTPase family and it is necessary to maintain the three dimensional architecture of podocytes and for them to function properly. It is important that Rac1 activity is properly regulated in podocytes.
We have genetically engineered experimental mice that express a hyper-active mutant form of Rac1 specifically within podocytes. When the hyper-active
Rac1 is induced in these mice, they exhibit protein loss in the urine, kidney scarring and other problems associated with diseases of the glomerulus.
We propose to study in detail how Rac1 affects the health of podocytes and how this protein can be targeted to treat NS, thereby improving the quality of the lives of people afflicted with the disease.
Department
Program
Travel Awards - Institute Community Support
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
337249
Name
Robins Richard
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Institute of Nutrition, Metabolism and Diabetes
Projecttitle
The Spectrum of Nephrotic Syndrome from Minimal Change Disease to FSGS Correlates with Rac1 Activation
Programtype2
Undefined
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$1,500
Cihrequipment2
$0
Programname2
Travel Awards - Institute Community Support
Keyworddelim
Focal Segmental Glomerlosclerosis; Minimal Change Disease; Nephrotic Syndrome; Podocytes; Rac1
Abstract
The main function of the kidneys is to filter the blood of waste products and produce urine. Within the kidneys are millions of glomeruli (singular:glomerulus) which are the sites where urine formation begins. The glomerulus functions as a filtration barrier that prevents the loss of important blood proteins into the urine. Nephrotic Syndrome (NS) is a disorder of the kidney
in which this filtration barrier is damaged and blood proteins are lost into the urine. It is common among children. The
consequences of heavy protein loss can include edema (swelling), infections, blood clots and in severe cases, the need for dialysis or
kidney transplantation to halt the protein loss. The severity and responsiveness to steroids is variable in NS.
The kidney's filtration barrier contains a population of cells known as podocytes
that are necessary for filtration function. Podocytes have a unique three-dimensional architecture with numerous small projections called foot processes that physically wrap around blood vessels, thereby blocking protein spillage into the urine. A family of proteins called Rho-GTPases regulate the three dimensional architecture of podocytes. The protein known as Rac1, is a key member
of the Rho-GTPase family and it is necessary to maintain the three dimensional architecture of podocytes and for them to function properly. It is important that Rac1 activity is properly regulated in podocytes.
We have genetically engineered experimental mice that express a hyper-active mutant form of Rac1 specifically within podocytes. When the hyper-active
Rac1 is induced in these mice, they exhibit protein loss in the urine, kidney scarring and other problems associated with diseases of the glomerulus.
We propose to study in detail how Rac1 affects the health of podocytes and how this protein can be targeted to treat NS, thereby improving the quality of the lives of people afflicted with the disease.
Competitiondate
201510
Approvedterm2
1 yr 0 mth
Pinamesdelim
Robins, Richard
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $1,500~ $0~